Previous Article | Next Article ![]()
Journal of Virology, November 1999, p. 9614-9618, Vol. 73, No. 11
Department of Molecular and Structural
Biology1 and Department of Medical
Microbiology and Immunology,3 University of
Aarhus, DK-8000 Aarhus C, Denmark, and Institute for Molecular
Virology, GSF-National Research Center for Environment and
Health, D-85764 Neuherberg, Germany2
Received 9 June 1999/Accepted 30 July 1999
A panel of mouse T-cell lymphomas induced by SL3-3 murine leukemia
virus (MLV) and three primer binding site mutants thereof (A. H. Lund, J. Schmidt, A. Luz, A. B. Sørensen, M. Duch, and F. S. Pedersen, J. Virol. 73:6117-6122, 1999) were analyzed for the
occurrence of recombination between the exogenous input virus and
endogenous MLV-like sequences within the 5' leader region. Evidence of
recombination within the region studied was found in 14 of 52 tumors
analyzed. Sequence analysis of a ~330-bp fragment of 44 chimeric
proviruses, encompassing the U5, the primer binding site, and the
upstream part of the 5' untranslated region, enabled us to map
recombination sites, guided by distinct scattered nucleotide differences. In 30 of 44 analyzed sequences, recombination was mapped
to a 33-nucleotide similarity window coinciding with the kissing-loop
stem-loop motif implicated in dimerization of the diploid genome.
Interestingly, the recombination pattern preference found in
replication-competent viruses from T-cell tumors is very similar to the
pattern previously reported for retroviral vectors in cell culture
experiments. The data therefore sustain the hypothesis that the kissing
loop, presumably via a role in RNA dimer formation, constitutes a hot
spot for reverse transcriptase-mediated recombination in MLV.
Recombination by template switching
between heterologous copackaged viral transcripts during reverse
transcription constitutes one mechanism by which retroviruses may
diversify and/or overcome the presence of otherwise incapacitating
mutations. Retroviruses are known to mutate at a high frequency
(11). Since neither of the two polymerases involved in
retroviral replication, RNA polymerase II or the virally encoded
reverse transcriptase (RT), harbors 3' In the present study, we have extended the analysis of 5' leader
recombination to replication-competent viruses by using an SL3-3 murine
leukemia virus (MLV) pathogenesis model. During analysis of a panel of
T-cell tumors derived from mice injected with wild-type (wt) and
PBS-modified SL3-3 viruses, we previously noted a number of
recombination events between the exogenous, injected SL3-3 virus and
MLV-like sequences endogenous to the mouse genome (12). In
this experiment, a wt SL3-3 MLV was compared to three virus mutants in
which the PBS had been mutated to match the 3' end of either
tRNA1Gln, tRNA3Lys, or
tRNA1,2Arg, and the viruses were compared in terms of
mean latency period prior to lymphoma induction, tumor cell origin, and
stability of the introduced mutations (12). To investigate
the stability of the introduced PBS mutations, segments from tumor
proviruses were PCR amplified and directly sequenced. In 14 of 52 analyzed tumors, the resulting sequence readouts were repeatedly highly ambiguous, with multiple double peaks consistent with simultaneous sequencing of different proviral templates (12).
Interestingly, evidence of recombination was most often detected in
tumors resulting from infection by the SL3-3-Lys3 mutant, since
chimeric proviruses were detected in 12 of 13 analyzed tumors.
Furthermore, the mean lymphoma latency period of this mutant was
significantly longer than that of wt SL3-3 MLV (12). We
ascribe this prolonged latency period, in combination with the high
frequency of detection of recombinant proviruses, to a diminished
replication capacity of the SL3-3-Lys3 mutant. However, the exact
reasons for this finding remain unclear. Interestingly, recombination
within the analyzed leader region was not limited to the apparently
stunted SL3-3-Lys3 mutant but could also be detected in one tumor
induced by the wt SL3-3-Pro as well as in one mutant harboring an
arginine PBS sequence (12).
To analyze in greater detail the structures of the chimeric tumor
proviruses from 13 of the tumors, PCR amplicons generated by using a
U3-specific primer (primer 1; 5'-GATTCCCAGATGACCGGGGATC-3') and a gag-specific primer (primer 2;
5'-TAGGGTCAGACTCAGAGGGGTGGT-3') were cloned into pGEM-T
(Promega) and individual subclones from each tumor were analyzed by
sequencing of approximately 400 bp of the U5-PBS-5' untranslated
leader region, using primer 1, primer 3 (5'-CGCAGGCGCAAAAAGTAGATGC-3'; specific for the leader
region), primer 4 (5'-TCCGAATCGTGGTCTCGCTGATCCTTGG-3';
specific for the U5 region), and primer 5 (5'-TTGCATCCGAATCGTGGTCWCGCT-3'; specific for the U5
region). All PCRs in this study were performed in 100 µl of PCR
buffer (Perkin-Elmer) containing 25 pmol of each primer, 0.2 mM each
deoxynucleoside triphosphate, and 3 U of AmpliTaq Gold polymerase
(Perkin-Elmer). Sequencing was performed on both strands with an
automated sequencer (ABI 373; Perkin-Elmer), using a Thermo Sequenase
II dye terminator cycle sequencing kit (Amersham Pharmacia Biotech).
The amplicons from each tumor were found to contain two types of
proviruses, the virus originally used to infect the mouse and a novel
chimeric provirus resulting from recombination between the injected
virus and endogenous MLV-like sequences and characterized by having a
PBS sequence matching the 3' end of a glutamine tRNA molecule. Aside
from the PBS-Gln, the chimeric proviruses contained a pattern of
nucleotide substitutions, deletions, and insertions relative to the
injected virus and exhibited a high degree of similarity to previously
characterized viruses endogenous to the mouse genome (3, 4, 13,
19). To retrieve sufficient subclones for subsequent analysis of
the pattern of recombination, the bacterial colonies from individual
subclonings were PCR screened with primer 2 and primer 6 (5'-GGGGGTCTTTCATTTGGAGGT-3'; specific for
PBS-Gln). From the resulting sequences, unique recombinants from each
tumor were aligned and compared to the sequence of the injected
SL3-3-Lys3 as well as to sequences of previously characterized endogenous MLVs.
As can be seen in Fig. 1, the recombinant
viruses contain a pattern of alterations relative to
SL3-3-Lys3. Within the ~330-bp sequence studied, the 22 markers
are relatively evenly distributed. Interestingly, whereas all of the
recombinants contain nucleotide alterations in the U5 region and the
upstream part of the 5' untranslated leader region, most of the
recombinants contain SL3-3-specific sequences in the downstream part of
the analyzed sequence window. Hence, the distinct differences between
the endogenous recombination partner and the injected virus may be used
as molecular markers to map the actual site of recombination. While
some of the genetic markers, such as IV, VIII, X, XI, and XII, are
ubiquitous, other positions are highly variable (for example, VI, VII,
and IX). Interestingly, some of the genetic markers are mutually
exclusive (for example, I and II/III), thus providing evidence that
several endogenous MLV loci are involved. Furthermore, marker XIV is
present in five different forms which, in combination with the mutually exclusive markers I and II/III, give rise to eight different
recombinants based on analysis of these four marker positions only.
However, the analyzed chimeric proviruses may result from independent
serial recombination events. Hence, the finding of a large number of different endogenous sequences frozen in the tumors at the time of
analysis could have resulted from initial recombinations involving only
two different endogenous MLV loci followed by additional secondary
recombinations and genetic drift within hypervariable-sequence regions.
Given the variation in the analyzed sequences and the fact that
recombinants can be found in SL3-3-Lys3-, SL3-3-Pro-, and
SL3-3-Arg1,2-induced tumors, it seems likely that recombination took
place during viral spread in the mice. However, prior to injection into
mice, the viruses used in this study were generated by transfection of
plasmid DNA into NIH 3T3 cells. The viruses were allowed to spread in
the cell culture, after which the stability of the introduced PBS
mutations was analyzed by reverse transcription-PCR and direct
sequencing of the resulting amplicon (12). While no evidence
of recombination was detected at this point at the level of sensitivity
of this assay, we cannot exclude the possibility of recombination
during viral growth in cell culture.
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
The Kissing-Loop Motif Is a Preferred Site of 5'
Leader Recombination during Replication of SL3-3 Murine Leukemia
Viruses in Mice
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
5' proofreading capability,
point mutations due to nucleotide misincorporation occur frequently
(1, 6, 21). Furthermore, the mechanism of reverse
transcription involves two strand transfer reactions which are
intrinsically erroneous (18, 20, 25). While these features
may allow rapid retroviral diversification, they also result in the
accumulation of defective viral genomes. Though unable to replicate
independently, such defective viral genomes may still be transcribed
and packaged into retroviral particles. Since retroviral particles
contain a diploid genome, defective viral genomes may be rescued
through recombinational patch repair with a heterologous, copackaged
genome, resulting in the formation of a new chimeric provirus (3,
5, 22, 24). In previous studies, we have analyzed recombination
events within the 5' untranslated region, using retroviral vectors
containing nonfunctional primer binding site (PBS) sequences (13,
14). By mutating a crucial viral cis element, such as
the PBS, normal vector transduction is impaired, thereby facilitating
the selection of rare transduction events, some of which result from
recombination events. In these studies, a hot spot for recombination
was found within the leader region (13, 14), coinciding
precisely with the kissing-loop stem-loop structure involved in
retroviral RNA dimer formation (7, 23).

View larger version (79K):
[in a new window]
FIG. 1.
Nucleotide sequences of cloned fragments of tumor
proviruses resulting from recombination within the leader region of
either SL3-3-Lys3, SL3-3-Arg1,2, or wt SL3-3-pro and endogenous
MLV-like sequences. The numbers refer to the distance from the
transcription initiation site. For comparison, the sequence of the
SL3-3-Lys3 U5-PBS-leader region is shown at the top. The sequences of
the PBS (nucleotides 145 to 162) and the kissing stem-loop (nucleotides
302 to 317) are underlined. Similarly, at the bottom are shown the
sequences of four different MLV-like sequences endogenous to the mouse
genome (3, 4, 13, 19). Nucleotides homologous to SL3-3 MLV
are indicated by hyphens, and deleted nucleotides are indicated by
colons. Nucleotide differences between SL3-3 and the endogenous
recombination partner (signified by Roman numerals) serve as molecular
markers for identification of the site of recombination.
From the alignment of 44 sequenced proviruses containing patches of endogenous MLV sequences of variable length, the actual site of recombination can be deduced from the presence or absence of specific marker mutations in the sequences (Fig. 1). Of the 44 recombinations, 42 took place within seven of the similarity windows studied whereas 2 map to sequences downstream. Within the sequence window studied, the distribution of the recombinations is highly skewed, with 30 of 44 recombination events taking place between markers XVI and XVIII. Two recombination events took place after marker XVIII, four recombination events occurred after marker XIX, and individual cases of recombination were detected after markers X, XIV, and XX. In some proviral sequences, individual point mutations are detected that are not present in SL3-3 or in any known endogenous MLV sequence (for example, position 362 in chimeric provirus 16.65 or position 389 in provirus 42.8). These mutations may have arisen independently during viral replication or the subsequent PCR amplification and were not taken into consideration when the site of recombination was mapped. However, base substitutions also found in endogenous viruses (for example, position 365 in provirus 41.50) or occurring repeatedly in different tumors (for example, position 339 [marker XIX] in proviruses 21.10, 21.42, 22.41, and 22.47) were taken into account when mapping the site of recombination.
The positions of the marker mutations relative to a putative secondary structure of the U5-PBS-5' leader region is shown in Fig. 2. Notably, most of the markers are in apparently nonpaired regions. An exception is a set of complementary mutations at positions 334 and 366, where a possible U-A base pair has been substituted for a C-G pair. Functional assignments have been established for stem-loops 2, (SL2), SL3, and SL4. SL2 contains the kissing-loop motif, a 16-nucleotide palindromic sequence thought to initiate the dimerization process (7). Marker XVII, an A-to-G substitution situated within the loop sequence of SL2, allows for the formation of an alternative dimer involving a G-U base pair. SL3 and SL4 constitute the core packaging signal of MLV (16). The structures of these SLs and the GACG loop sequences important for encapsidation (27) are unaffected by the marker mutations. Hence, none of the marker mutations in the 5' leader region are likely to have significantly affected the replication capacity of the chimeric viruses, in accordance with previous findings (3, 9). Importantly, in 30 of the 44 analyzed viruses, the site of recombination was found to overlap with the kissing-loop motif of SL2, indicating a functional importance of close RNA-RNA interactions in this region in mediating recombination.
|
In previous reports, a site preference for recombination within the MLV leader region was detected by using crippled Akv-MLV-derived retroviral vectors harboring nonfunctional PBS sequences (13, 14). By this approach, normal vector replication is impaired, enabling easy detection of rare transduction events involving recombinational patch repair by endogenous viral RNA of murine packaging cells. Using several different vector constructs, a hot spot for recombination corresponding to the region between markers XVI and XVIII was identified. As shown in Fig. 3, the recombinational cluster found in tumor proviruses and the hot spot for recombination identified in cell culture by using retroviral vectors coincide exactly. Obviously, selective forces other than recombination frequencies per se, such as effects on RNA processing or translation initiation, may operate during virus replication in animals. However, the finding of similar recombination patterns in single-cycle studies using retroviral vectors and in replication-competent proviruses from T-cell tumors indicates that within the 5' leader window studied here, the kissing-loop motif is particularly prone to recombination.
|
To explain both the cell culture and animal results, we favor a model involving RT-mediated homologous recombination facilitated by direct RNA base pairing at the dimer linkage structure. In this model (Fig. 3), a copy of the endogenous recombination partner is copackaged in vivo with a copy of the injected SL3-3 MLV. Minus-strand strong-stop DNA generated on the endogenous viral RNA is transferred to the 3' end of the SL3-3 genome (intermolecular strand transfer); this is followed by minus-strand synthesis of the SL3-3 coding region. An intermolecular strand transfer to the genome of the endogenous viral RNA sequence within the 5' leader region then serves to incorporate a PBS sequence matching tRNAGln, thereby facilitating the second jump of reverse transcription. Whereas local sequence identity and the length of similarity windows have previously been proposed to be major determinants in recombinogenic strand transfer (10, 28), data from our studies, obtained using both replication-competent viruses and retroviral vectors, underline the importance of specific RNA structures in promoting recombination within the 5' leader region. Similarly, recombination preferences mediated by pairing of RNA molecules have also been proposed for other RNA viruses (17).
Why is recombination preferentially seen in the kissing-loop motif? It can be speculated that RT pausing due to extended RNA base pairings in this region promotes template switching. Alternatively, recombination at the kissing-loop motif may be promoted by other factors dependent on base pairing, i.e., protein binding to the dimer linkage structure or forced copy choice template switching, perhaps even mediated by RT-mediated degradation of double-stranded RNA at the dimerization initiation site (2, 8). The presence of RNA structures mediating recombination may increase the speed of retroviral evolution by resulting in shuffling of existing mutations, thereby generate new combinations of variants, possibly with altered biological properties. The finding of kissing-loop-mediated recombinants in T-cell tumors induced by both wt and PBS-modified SL3-3 MLVs indicates that the kissing loop may be an important element in viral diversification.
| |
ACKNOWLEDGMENTS |
|---|
The technical assistance of Jane Jensen is gratefully acknowledged.
This work was supported by contracts CT 95-100 (Biotechnology) and CT 95-0675 (Biomed 2) of the European Commission, the Karen Elise Jensen Foundation, the Danish Cancer Society, the Danish Biotechnology Program, and the Danish Natural Sciences and Medical Research Councils.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Molecular and Structural Biology, University of Aarhus, C. F. Møllers Allé, Bldg. 130, DK-8000 Aarhus C, Denmark. Phone: 45 8942 3188. Fax: 45 8619 6500. E-mail: fsp{at}mbio.aau.dk.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Bebenek, K., and T. A. Kunkel. 1993. The fidelity of retroviral reverse transcriptases, p. 85-102. In A. M. Skalka, and S. P. Goff (ed.), Reverse transcriptase. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York. |
| 2. |
Blain, S. W., and S. P. Goff.
1993.
Nuclease activities of Moloney murine leukemia virus reverse transcriptase. Mutants with altered substrate specificities.
J. Biol. Chem.
268:23585-23592 |
| 3. | Colicelli, J., and S. P. Goff. 1987. Isolation of a recombinant murine leukemia virus utilizing a new primer tRNA. J. Virol. 57:37-45. |
| 4. | Colicelli, J., and S. P. Goff. 1987. Identification of endogenous retroviral sequences as potential donors for recombinational repair of mutant retroviruses: positions of cross-over point. Virology 160:518-522[Medline]. |
| 5. |
DiFronzo, N. L., and C. A. Holland.
1993.
A direct demonstration of recombination between an injected virus and endogenous viral sequences, resulting in the generation of mink cell focus-inducing viruses in AKR mice.
J. Virol.
67:3763-3770 |
| 6. |
Dougherty, J. P., and H. M. Temin.
1988.
Determination of the rate of base-pair substitution and insertion mutations in retrovirus replication.
J. Virol.
62:2817-2822 |
| 7. | Girard, P.-M., B. Bonnet-Mathoniére, D. Muriaux, and J. Paoletti. 1995. A short autocomplementary sequence in the 5' leader region is responsible for dimerization of MoMuLV genomic RNA. Biochemistry 34:9785-9794[Medline]. |
| 8. | Götte, M., S. Fackler, T. Hermann, E. Perola, L. Cellai, H. J. Gross, S. F. Le Grice, and H. Heumann. 1995. HIV-1 reverse transcriptase-associated RNase H cleaves RNA/RNA in arrested complexes: implications for the mechanism by which RNase H discriminates between RNA/RNA and RNA/DNA. EMBO J. 14:833-841[Medline]. |
| 9. |
Grez, M.,
E. Akgün,
F. Hilberg, and W. Ostertag.
1990.
Embryonic stem cell virus, a recombinant murine retrovirus with expression in embryonic stem cells.
Proc. Natl. Acad. Sci. USA
87:9202-9206 |
| 10. |
Hu, W.-S., and H. M. Temin.
1990.
Retroviral recombination and reverse transcription.
Science
250:1227-1233 |
| 11. | Katz, R. A., and A. M. Skalka. 1990. Generation of diversity in retroviruses. Annu. Rev. Genet. 24:409-445[Medline]. |
| 12. |
Lund, A. H.,
J. Schmidt,
A. Luz,
A. B. Sørensen,
M. Duch, and F. S. Pedersen.
1999.
Replication and pathogenicity of primer binding site mutants of SL3-3 murine leukemia viruses.
J. Virol.
73:6117-6122 |
| 13. | Mikkelsen, J. G., A. H. Lund, K. D. Kristensen, M. Duch, M. S. Sørensen, P. Jørgensen, and F. S. Pedersen. 1996. A preferred region for recombinational patch repair in the 5' untranslated region of primer binding site-impaired murine leukemia virus vectors. J. Virol. 70:1439-1447[Abstract]. |
| 14. |
Mikkelsen, J. G.,
A. H. Lund,
M. Duch, and F. S. Pedersen.
1998.
Recombination in the 5' leader of murine leukemia virus is accurate and influenced by sequence identity with a strong bias toward the kissing-loop dimerization region.
J. Virol.
72:6967-6978 |
| 15. |
Mougel, M.,
N. Tounekti,
J.-L. Darlix,
J. Paoletti,
B. Ehresmann, and C. Ehresmann.
1993.
Conformational analysis of the 5' leader and the gag initiation site of Mo-MuLV RNA and allosteric transitions induced by dimerization.
Nucleic Acids Res.
21:4677-4684 |
| 16. |
Mougel, M.,
Y. Zhang, and E. Barklis.
1996.
cis-active structural motifs involved in specific encapsidation of Moloney murine leukemia virus RNA.
J. Virol.
70:5043-5050 |
| 17. | Nagy, P. D., and A. E. Simon. 1997. New insights into the mechanisms of RNA recombination. Virology 235:1-9[Medline]. |
| 18. |
Olsen, J. C.,
C. Bova-Hill,
D. P. Grandgenett,
T. P. Quinn,
J. P. Manfredi, and R. Swanstrom.
1990.
Rearrangements in unintegrated retroviral DNA are complex and are the result of multiple genetic determinants.
J. Virol.
64:5475-5484 |
| 19. |
Ou, C.-Y.,
L. R. Boone, and W. K. Yang.
1983.
A novel sequence segment and other nucleotide structural features in the long terminal repeat of a BALB/c mouse genomic murine leukemia virus-related DNA clone.
Nucleic Acids Res.
11:5603-5620 |
| 20. |
Pulsinelli, G. A., and H. M. Temin.
1991.
Characterization of large deletions occurring during a single round of retrovirus vector replication: novel deletion mechanism involving errors in strand transfer.
J. Virol.
65:4786-4797 |
| 21. |
Roberts, J. D.,
B. D. Preston,
L. A. Johnston,
A. Soni,
L. A. Loeb, and T. A. Kunkel.
1989.
Fidelity of two reverse transcriptases during DNA-dependent DNA synthesis in vitro.
Mol. Cell. Biol.
9:469-476 |
| 22. |
Schwartzberg, P.,
J. Colicelli, and S. P. Goff.
1985.
Recombination between a defective retrovirus and homologous sequences in host DNA: reversion by patch repair.
J. Virol.
53:719-726 |
| 23. |
Skripkin, E.,
J. C. Paillart,
R. Marquet,
B. Ehresmann, and C. Ehresmann.
1994.
Identification of the primary site of human immunodeficiency virus type 1 RNA dimerization in vitro.
Proc. Natl. Acad. Sci. USA
91:4945-4949 |
| 24. |
Stuhlmann, H., and P. Berg.
1992.
Homologous recombination of copackaged retrovirus RNAs during reverse transcription.
J. Virol.
66:2378-2388 |
| 25. |
Temin, H. M.
1993.
Retrovirus variation and reverse transcription: abnormal strand transfers result in retrovirus genetic variation.
Proc. Natl. Acad. Sci. USA
90:6900-6903 |
| 26. | Tounekti, N., M. Mougel, C. Roy, R. Marquet, J.-L. Darlix, J. Paoletti, B. Ehresmann, and C. Ehresmann. 1992. Effect of dimerization on the conformation of the encapsidation Psi domain of Moloney murine leukemia virus RNA. J. Mol. Biol. 223:205-220[Medline]. |
| 27. | Yang, S., and H. M. Temin. 1994. A double hairpin structure is necessary for the efficient encapsidation of spleen necrosis virus retroviral RNA. EMBO J. 13:713-726[Medline]. |
| 28. |
Zhang, J., and H. M. Temin.
1994.
Retrovirus recombination depends on the length of sequence identity and is not error prone.
J. Virol.
68:2409-2414 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»